1) Platetet inhibition
抗血小板凝聚
2) Platelet aggregation
血小板凝聚
1.
Whole blood viscosity and plasma viscosity were evaluated by cone-plate viscometer, hematocrit was determined by micro-capillary method, platelet aggregation was measured by photoelectric turbidimetry and coagulation parameters were evaluated by optical electromagnetic method.
在切变率200～1s-1范围内采用锥板法测定全血粘度和血浆粘度;微量毛细管法测定红细胞压积;光电比浊法测定二磷酸腺苷(ADP)诱导的血小板凝聚和光电电磁法测定凝血参数。
3) agkisacutacin
抗血小板凝集素
4) platelet aggregation inhibitors
抗血小板凝集剂
6) Anti-platelet aggregation
抗血小板聚集
1.
Study on the active compounents of anti-platelet aggregation from pine needles of Pinus massoniana Lamb;
马尾松松针抗血小板聚集活性的成分考察
2.
Synthesis and anti-platelet aggregation activities in vitro of rutaecarpine derivatives;
Rutaecarpine衍生物的合成及体外抗血小板聚集活性
3.
Expression,purification and characterization of a novel staphylokinase with anti-platelet aggregation activity;
具有抗血小板聚集功能的新型葡激酶突变体的表达、纯化及性质
补充资料：抗血小板药
分子式：
CAS号：
性质：血小板功能与动脉粥样硬化有密切的关系，动脉粥样硬化患者多有血小板功能亢进的现象。血小板功能低下者不易发生动脉粥样硬化。抗血小板药通过从不同环节或途径对血小板起抑制作用，减少动脉粥样硬化疾病的发生。主要包括阿司匹林(乙酰水杨酸)、苯磺唑酮(苯磺保泰松)、潘生丁、前列腺素。
CAS号：
性质：血小板功能与动脉粥样硬化有密切的关系，动脉粥样硬化患者多有血小板功能亢进的现象。血小板功能低下者不易发生动脉粥样硬化。抗血小板药通过从不同环节或途径对血小板起抑制作用，减少动脉粥样硬化疾病的发生。主要包括阿司匹林(乙酰水杨酸)、苯磺唑酮(苯磺保泰松)、潘生丁、前列腺素。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条